Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Nov 17, 2021 10:26pm
113 Views
Post# 34139080

RE:The burying of the 6.6M CAD revenue from Baxter was a 20yr.

RE:The burying of the 6.6M CAD revenue from Baxter was a 20yr.

SouthernTierTom wrote: low from a strategic or ethical point of view.

Splitting the 5M USD or 6.6M CAD in early 2020 into 108 tiny 61K pieces on the back of FULL Covid 19 approval for PMX both in Canada and here in the US was the "low water mark" for the "corporate limbo contest" - IMHO.  Add the fact they delivered a 'previously arranged" 1.7M CAD "legacy charge" ( lump sum, not split in 108 spectral pieces ) to turn the quarter into a trememdous ME$$, gave you have a launch pad for the knew era of insider fulfillment.

The 60 cent Paradigm financing and of course the 42.5 cent Paradigm financing here in the US.

Where is Toray at ~ 22% ownership and Birch Hill at ~ 16% ownership to "call out" the activity.  Aside from the Birch Hill director buying the expiring 45 cent warrants ( April 2021 ) from an "undisclosed source", we have little to no market support from the BIG 2 shareholders.

Birch Hill has NEVER included us in their "investment portfolio / partner" ( well over a decade of website silence )
section of their website.  A small ask for a huge ownership in our curious "trials and tribulations" 

Please feel free to suggest how we right the ship that appears exactly on course ; - )


I'd say she is listing , by about 15 degrees... but only on Canadian waters... not so much on US waters  

Maybe we need to put some more heavy substance in its bilge  ... and maybe get rid of the bilge rats 


MM 
 

<< Previous
Bullboard Posts
Next >>